Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Gill

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Gates Open Research|July 18, 2020
Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South AfricaJennifer F Morton, Laura Myers, Katherine Gill, et al.
Sexually Transmitted Infections|July 2, 2026
Cervicovaginal inflammation and HIV target cell activation in adolescent girls and young women with <i>Chlamydia trachomatis</i> infectionsSmritee Dabee, Shaun Barnabas, Brian Kullin, et al.
Journal of the International AIDS Society|October 9, 2020
An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)Katherine Gill, Anna-Ursula Happel, Tanya Pidwell, et al.
Frontiers in Reproductive Health|October 28, 2022
Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized TrialChristina Balle, Prachi M Gupta, Gregory K Tharp, et al.
AIDS (London, England)|June 9, 2026
Adherence, acceptability, preference and safety of placebo Long-Acting Pre-exposure Prophylaxis (LA-PrEP) injections and implants for HIV-Prevention in South African MenElizabeth T Montgomery, Thesla Palanee-Phillips, Millicent Atujuna, et al.
Sexually Transmitted Infections|September 29, 2020
Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trialChristina Balle, Katherine Gill, Iyaloo N Konstantinus, et al.
Frontiers in Reproductive Health|December 12, 2024
Ecology meets reproductive medicine in HIV prevention: the case for geography-informed approaches for bacterial vaginosis in AfricaJo-Ann S Passmore, Sinaye Ngcapu, Serah Gitome, et al.
The Journal of Infectious Diseases|January 29, 2026
High Prevalence and Genotypic Diversity of Persistent Chlamydia Trachomatis Infections Among South African Adolescent Girls and Young Women: A Tale of Two CitiesSmritee Dabee, Shaun Barnabas, Bart Versteeg, et al.
The Lancet. HIV|February 4, 2021
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension studyAnnalene Nel, Neliëtte van Niekerk, Ben Van Baelen, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Gates Open Research|July 18, 2020
Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South AfricaJennifer F Morton, Laura Myers, Katherine Gill, et al.
Sexually Transmitted Infections|July 2, 2026
Cervicovaginal inflammation and HIV target cell activation in adolescent girls and young women with <i>Chlamydia trachomatis</i> infectionsSmritee Dabee, Shaun Barnabas, Brian Kullin, et al.
Journal of the International AIDS Society|October 9, 2020
An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)Katherine Gill, Anna-Ursula Happel, Tanya Pidwell, et al.
Frontiers in Reproductive Health|October 28, 2022
Systems Analysis Reveals Contraceptive-Induced Alteration of Cervicovaginal Gene Expression in a Randomized TrialChristina Balle, Prachi M Gupta, Gregory K Tharp, et al.
AIDS (London, England)|June 9, 2026
Adherence, acceptability, preference and safety of placebo Long-Acting Pre-exposure Prophylaxis (LA-PrEP) injections and implants for HIV-Prevention in South African MenElizabeth T Montgomery, Thesla Palanee-Phillips, Millicent Atujuna, et al.
Sexually Transmitted Infections|September 29, 2020
Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trialChristina Balle, Katherine Gill, Iyaloo N Konstantinus, et al.
Frontiers in Reproductive Health|December 12, 2024
Ecology meets reproductive medicine in HIV prevention: the case for geography-informed approaches for bacterial vaginosis in AfricaJo-Ann S Passmore, Sinaye Ngcapu, Serah Gitome, et al.
The Journal of Infectious Diseases|January 29, 2026
High Prevalence and Genotypic Diversity of Persistent Chlamydia Trachomatis Infections Among South African Adolescent Girls and Young Women: A Tale of Two CitiesSmritee Dabee, Shaun Barnabas, Bart Versteeg, et al.
The Lancet. HIV|February 4, 2021
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension studyAnnalene Nel, Neliëtte van Niekerk, Ben Van Baelen, et al.
Medrxiv : the Preprint Server for Health Sciences|September 21, 2021
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine EvaluationYunda Huang, Oleg Borisov, Jia Jin Kee, et al.
Pageof 8